Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Beam Therapeutics Inc. | Chief Medical Officer | Common Stock | 68.8K | $1.58M | $22.95 | Jul 2, 2024 | Direct |
Beam Therapeutics Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 55K | $1.34M | $24.40 | Jan 31, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BEAM | Beam Therapeutics Inc. | Jul 1, 2024 | 2 | -$29.1K | 4 | Jul 3, 2024 | Chief Medical Officer |
BEAM | Beam Therapeutics Inc. | Apr 1, 2024 | 2 | -$735K | 4 | Apr 3, 2024 | Chief Medical Officer |
BEAM | Beam Therapeutics Inc. | Mar 31, 2024 | 1 | $0 | 4 | Apr 2, 2024 | Chief Medical Officer |
BEAM | Beam Therapeutics Inc. | Jan 31, 2024 | 1 | $1.34M | 4 | Feb 2, 2024 | Chief Medical Officer |
BEAM | Beam Therapeutics Inc. | Oct 30, 2023 | 1 | -$64.5K | 4 | Nov 1, 2023 | Chief Medical Officer |
BEAM | Beam Therapeutics Inc. | Jul 10, 2023 | 1 | -$11.9K | 4 | Aug 9, 2023 | Chief Medical Officer |
BEAM | Beam Therapeutics Inc. | Apr 3, 2023 | 3 | -$481K | 4 | Apr 5, 2023 | Chief Medical Officer |
BEAM | Beam Therapeutics Inc. | Mar 31, 2023 | 1 | $0 | 4 | Mar 31, 2023 | Chief Medical Officer |
BEAM | Beam Therapeutics Inc. | Mar 16, 2023 | 0 | $0 | 3 | Mar 27, 2023 | Chief Medical Officer |